Is subretinal surgery feasible for a non-responsive juxtafoveal type 2 choroidal neovascular membrane?

To describe the long-term outcome of a patient with multifocal choroiditis, who underwent surgical removal of a type 2 choroidal neovascular membrane employing 23 G pars plana vitrectomy. A 50-year-old man was treated with 3 monthly intravitreal bevacizumab injections, but despite treatment, visual...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of ophthalmology case reports Vol. 15; p. 100460
Main Authors Quiroz-Mercado, Hugo, Lisker-Cervantes, Andrés, Arroyo, Luis, Mandava, Naresh, Siringo, Frank S, Paciuc-Beja, Miguel, Gonzalez-Salinas, Roberto
Format Journal Article
LanguageEnglish
Published United States Elsevier 01.09.2019
Subjects
Case Report
Pars plana vitrectomy
Anti-VEGF therapy
Spectral-domain optical coherence tomography
Choroidal neovascular membrane
Online AccessGet full text

Cover

More Information
Summary:To describe the long-term outcome of a patient with multifocal choroiditis, who underwent surgical removal of a type 2 choroidal neovascular membrane employing 23 G pars plana vitrectomy. A 50-year-old man was treated with 3 monthly intravitreal bevacizumab injections, but despite treatment, visual acuity continued to worsen from 20/40 to 20/100, and bleeding was not receding. A minimal invasive pars plana vitrectomy was performed for surgical removal of the neovascular complex without any complicating incident. Subsequent visual acuity was 20/25 for more than eleven years. Surgical removal of choroidal neovascular membranes employing minimal invasive surgery in addition to anti-VEGF therapy, and OCT evaluation can be a viable approach for selected cases of juxtafoveal type 2 CNV.
ISSN:2451-9936
2451-9936
DOI:10.1016/j.ajoc.2019.100460